A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind
{{output}}
Chemotherapy remains a commonly used and important treatment option for metastatic breast cancer. A majority of Estrogen Receptor-positive (ER + ) metastatic breast cancer patients ultimately develop resistance to chemotherapy, resulting in disease progression... ...
